Michael Hölzel
- Immunology top 2%
- Immunotherapy and Immune Responses 10
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 18
- CAR-T cell therapy research 7
- Cancer Research top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 8
- Neurology top 5%
-
- Bladder and Urothelial Cancer Treatments 10
- Urinary and Genital Oncology Studies 7
-
- Meningioma and schwannoma management 7
-
- Renal cell carcinoma treatment 6
- Co-authors
- Thomas TütingDirk EickTobias BaldRohrmoser MichaelaMalamoussi AnastassiaElisabeth KremmerJennifer LandsbergAnton Bovier
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Cancers (5 papers)Journal of Clinical Oncology (5 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Hölzel
91 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 113
- Immunology 1.3k
- Oncology 1.7k
- Cancer Research 588
- Molecular Biology 2.2k
- Neurology 281
Countries citing papers authored by Michael Hölzel
This map shows the geographic impact of Michael Hölzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hölzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hölzel more than expected).
Fields of papers citing papers by Michael Hölzel
This network shows the impact of papers produced by Michael Hölzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hölzel. The network helps show where Michael Hölzel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Hölzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 17 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 53 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 88 | |
| 14 | 2019 | 6 | |
| 15 | 2017 | 76 | |
| 16 | 2015 | 30 | |
| 17 | 2015 | 153 | |
| 18 | 2014 | 196 | |
| 19 | 2011 | 147 | |
| 20 | 2009 | 112 |
About Michael Hölzel
Michael Hölzel is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 96 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (10 papers), Bladder and Urothelial Cancer Treatments (10 papers), Epigenetics and DNA Methylation (8 papers), Urinary and Genital Oncology Studies (7 papers), CAR-T cell therapy research (7 papers), Meningioma and schwannoma management (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.7k citations) and Cancer Research (588 citations). Michael Hölzel has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thomas Tüting, Dirk Eick, Tobias Bald, Rohrmoser Michaela, Malamoussi Anastassia, Elisabeth Kremmer, Jennifer Landsberg, Anton Bovier, Harasim Thomas and Marcel Renn. Their work appears in journals such as Cancers, Journal of Clinical Oncology, Journal of Biological Chemistry, Journal for ImmunoTherapy of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.